CN Patent

CN1925847A — 增强欧司哌米芬生物利用度的方法

Assigned to Hormos Medical Ltd Oy · Expires 2007-03-07 · 19y expired

What this patent protects

本发明涉及增强欧司哌米芬(ospemifene)或者其几何异构体、立体异构体、药学上活性的盐、酯或者其代谢产物的生物利用度的方法，其中所述化合物连同食物摄入一起口服给药至个体。本发明还涉及骨质疏松、皮肤萎缩、上皮和粘膜萎缩的治疗或者预防，以及涉及尿道或者阴道症状的治疗或者预防。

USPTO Abstract

本发明涉及增强欧司哌米芬(ospemifene)或者其几何异构体、立体异构体、药学上活性的盐、酯或者其代谢产物的生物利用度的方法，其中所述化合物连同食物摄入一起口服给药至个体。本发明还涉及骨质疏松、皮肤萎缩、上皮和粘膜萎缩的治疗或者预防，以及涉及尿道或者阴道症状的治疗或者预防。

Drugs covered by this patent

Patent Metadata

Patent number
CN1925847A
Jurisdiction
CN
Classification
—
Expires
2007-03-07
Drug substance claim
No
Drug product claim
No
Assignee
Hormos Medical Ltd Oy
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.